SCHEMBL3720640

SCHEMBL3720640

Oc1ccc(NCC2CC2)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
S1PR1 P21453 1/20 0.43
ESR2 Q92731 6/20 0.42
ESR1 P03372 5/20 0.42
CYP3A4 P08684 2/20 0.42
CYP2C9 P11712 2/20 0.42
USP7 Q93009 1/20 0.42
L3MBTL1 Q9Y468 4/20 0.41
MEN1 O00255 3/20 0.41
ALDH1A1 P00352 3/20 0.41
POLB P06746 3/20 0.41
MAPT P10636 3/20 0.41
ALOX15 P16050 3/20 0.41
CASP1 P29466 3/20 0.41
BLM P54132 3/20 0.41
KMT2A Q03164 3/20 0.41
HSD17B10 Q99714 3/20 0.41
GAA P10253 2/20 0.41
HPGD P15428 2/20 0.41
MAPK1 P28482 2/20 0.41
KDM4E B2RXH2 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16411283 0.92 S1PR1 (0.47) S1PR1ESR2ESR1CYP3A4CYP2C9
SCHEMBL6884915 0.90 S1PR1 (0.52) S1PR1MEN1ALDH1A1MAPTKMT2A
SCHEMBL28188626 0.87 MEN1 (0.46) S1PR1ESR2ESR1CYP3A4CYP2C9
SCHEMBL21309864 0.79 ACHE (0.39) CYP2C9MEN1ALDH1A1MAPTKMT2A
Phenol SCHEMBL28188627 0.79 CARM1 (0.48) S1PR1CYP3A4CYP2C9MEN1ALDH1A1
SCHEMBL10398544 0.79 NPC1 (0.41) L3MBTL1MEN1ALDH1A1POLBMAPT
SCHEMBL25330831 0.78 JAK2 (0.45) ALDH1A1POLBMAPK1KDM4ECARM1
SCHEMBL2935193 0.78 PTGER4 (0.42) CYP3A4CYP2C9L3MBTL1MEN1ALDH1A1
SCHEMBL3717751 0.78 RAB9A (0.44) L3MBTL1MEN1ALDH1A1MAPTKMT2A
SCHEMBL10187375 0.78 PTGER4 (0.42) CYP3A4CYP2C9L3MBTL1MEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 51 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240245699-A1 PYRROLE COMPOUNDS, A PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM SERVIER LAB (FR) 2024-07-25 US disclosed
US-20210290631-A1 PYRROLE COMPOUNDS, A PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM LES LABORATOIRES SERVIER (FR) 2021-09-23 US disclosed
US-11058689-B2 Pyrrole compounds, a process for their preparation and pharmaceutical LES LABORATOIRES SERVIER (FR) 2021-07-13 US disclosed
US-20200261464-A1 PYRROLE COMPOUNDS, A PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM LES LABORATOIRES SERVIER (FR) 2020-08-20 US disclosed
US-10688101-B2 Pyrrole compounds, a process for their preparation and pharmaceutical compositions containing them LES LABORATORIES SERVIER (FR) 2020-06-23 US disclosed
US-10662173-B2 Indole and pyrrole compounds, a process for their preparation and pharmaceutical compositions containing them LES LABORATOIRES SERVIER (FR) 2020-05-26 US disclosed
US-10414754-B2 Indolizine compounds, a process for their preparation and pharmaceutical compositions containing them LES LABORATOIRES SERVIER (FR) 2019-09-17 US disclosed
US-20190192528-A1 PYRROLE COMPOUNDS, A PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM LES LABORATOIRES SERVIER (FR) 2019-06-27 US disclosed
US-10265323-B2 Pyrrole compounds, a process for their preparation and pharmaceutical compositions containing them LES LABORATOIRES SERVIER (FR) 2019-04-23 US disclosed
US-10258626-B2 Indolizine compounds, a process for their preparation and pharmaceutical compositions containing them LES LABORATORIES SERVIER (FR) 2019-04-16 US disclosed
US-20150051189-A1 INDOLIZINE COMPOUNDS, A PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM VERNALIS (R&D) LTD (GB) 2015-02-19 US disclosed
US-20150031648-A1 PHOSPHATE COMPOUNDS, A PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM LES LABORATOIRES SERVIER (FR) 2015-01-29 US disclosed
WO-2015011397-A1 NOVEL INDOLIZINE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME LES LABORATOIRES SERVIER (FR) 2015-01-29 WO disclosed
WO-2015011400-A1 NOVEL PYRROLE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME LES LABORATOIRES SERVIER (FR) 2015-01-29 WO disclosed
US-20150031673-A1 PYRROLE COMPOUNDS, A PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM LES LABORATOIRES SERVIER (FR) 2015-01-29 US disclosed
WO-2015011396-A1 NOVEL DERIVATIVES OF INDOLE AND PYRROLE, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME LES LABORATOIRES SERVIER (FR) 2015-01-29 WO disclosed
EP-2829545-A1 New phosphate derivatives, method of preparing same and pharmaceutical compositions containing them Les Laboratoires Servier (FR) 2015-01-28 EP disclosed
EP-2829539-A1 New pyrrole derivatives, method of preparing same and pharmaceutical compositions containing them Les Laboratoires Servier (FR) 2015-01-28 EP disclosed
CN-104144930-A New indolizine derivatives, method for preparing same and pharmaceutical compositions containing same SERVIER LAB 2014-11-12 CN disclosed
WO-2010127208-A1 INHIBITORS OF ACETYL-COA CARBOXYLASE FOREST LABORATORIES HOLDINGS LIMITED (BM) 2010-11-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (13 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10662173-B2 Indole and pyrrole compounds, a process for their preparation and pharmaceutical compositions containing them RB1, IDO1, BCL2A1 S1PR1 454/4885ESR2 2212/4885ESR1 2867/4885
US-11058689-B2 Pyrrole compounds, a process for their preparation and pharmaceutical PDCD11, RRM2B, RRS1 S1PR1 353/4885ESR2 1536/4885ESR1 1668/4885
US-20210290631-A1 PYRROLE COMPOUNDS, A PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM PDCD11, RRM2, RRM2B S1PR1 501/4885ESR2 1696/4885ESR1 1470/4885
US-20150031673-A1 PYRROLE COMPOUNDS, A PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM PDCD11, RRM2B, RRM2 S1PR1 591/4885ESR2 1447/4885ESR1 1967/4885
US-20200261464-A1 PYRROLE COMPOUNDS, A PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM PDCD11, RRS1, RRM2B S1PR1 527/4885ESR2 1459/4885ESR1 2035/4885
US-10258626-B2 Indolizine compounds, a process for their preparation and pharmaceutical compositions containing them IDO1, IDO2, API5 S1PR1 1149/4885ESR2 978/4885ESR1 670/4885
US-10414754-B2 Indolizine compounds, a process for their preparation and pharmaceutical compositions containing them IDO1, API5, IDO2 S1PR1 1643/4885ESR2 1119/4885ESR1 777/4885
US-20240245699-A1 PYRROLE COMPOUNDS, A PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM PDCD11, RRM2B, RRM2 S1PR1 591/4885ESR2 1447/4885ESR1 1967/4885
US-10688101-B2 Pyrrole compounds, a process for their preparation and pharmaceutical compositions containing them PDCD11, RRM2B, RRM2 S1PR1 591/4885ESR2 1447/4885ESR1 1967/4885
US-20150051189-A1 INDOLIZINE COMPOUNDS, A PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM IDO1, IDO2, API5 S1PR1 1149/4885ESR2 978/4885ESR1 670/4885
US-20190192528-A1 PYRROLE COMPOUNDS, A PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM PDCD11, RRM2B, RRM2 S1PR1 591/4885ESR2 1447/4885ESR1 1967/4885
US-20150031648-A1 PHOSPHATE COMPOUNDS, A PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM ENPP2, RB1, RRM2 S1PR1 240/4885ESR2 1209/4885ESR1 2302/4885
US-10265323-B2 Pyrrole compounds, a process for their preparation and pharmaceutical compositions containing them PDCD11, RRM2B, RRM2 S1PR1 591/4885ESR2 1447/4885ESR1 1967/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.